From: A 19-Gene expression signature as a predictor of survival in colorectal cancer
Genes | Univariate | Multivariate | ||
---|---|---|---|---|
 | Hazard ratio (95 % CI) | p-value | Hazard ratio (95 % CI) | p-value |
NOTCH2 | 1.356 (1.154 – 1.592) | 0.000 *** | 1.56 (1.034 – 1.913) | 0.009 ** |
ITPRIP | 1.063 (0.919 – 1.23) | 0.408 | 0.852 (0.614 – 1.183) | 0.340 |
FRMD6 | 1.259 (1.092 – 1.452) | 0.001 ** | 1.066 (0.850 – 1.338) | 0.575 |
GFRA4 | 0.860 (0.728 – 1.016) | 0.005 ** | 0.871 (0.547 – 1.005) | 0.010 ** |
OSBPL9 | 0.803 (0.671 – 0.962) | 0.017 ** | 0.818 (0.640 – 1.045) | 0.047 ** |
CPXCR1 | 0.918 (0.811 – 1.041) | 0.183’ | 1.030 (0.766 – 1.387) | 0.840 |
SORCS2 | 1.159 (1.041 – 1.290) | 0.006 ** | 0.936 (0.752 – 1.166) | 0.558 |
PDC | 0.812 (0.679 – 0.970) | 0.022 ** | 1.068 (0.796 – 1.432) | 0.659 |
C12orf66 | 0.902 (0.808 – 1.008) | 0.069 * | 1.007 (0.729 – 1.390) | 0.965 |
SLC38A9 | 0.919 (0.845 – 1.000) | 0.050 * | 1.073 (0.894 – 1.289) | 0.443 |
OR10H5 | 0.846 (0.704 – 1.018) | 0.075 * | 1.078 (0.826 – 1.407) | 0.579 |
TRIP13 | 0.881 (0.802 – 0.968) | 0.008 ** | 0.985 (0.780 – 1.244) | 0.901 |
MRPL52 | 0.848 (0.767 – 0.939) | 0.001 ** | 0.865 (0.697 – 1.075) | 0.019 ** |
DUSP21 | 0.903 (0.807 – 1.011) | 0.077 * | 0.928 (0.697 – 1.235) | 0.609 |
BRCA1 | 0.836 (0.764 – 0.915) | 0.000 *** | 0.884 (0.713 – 1.097) | 0.264 |
ELTD1 | 1.155 (1.021 – 1.307) | 0.021 ** | 0.969 (0.772 – 1.216) | 0.787 |
SPG7 | 1.141 (1.035 – 1.259) | 0.008 ** | 1.026 (0.840 – 1.255) | 0.797 |
LASS6 | 0.867 (0.782 – 0.961) | 0.006 ** | 0.788 (0.631 – 0.984) | 0.035 ** |
DUOX2 | 1.076 (0.975 – 1.187) | 0.141’ | 1.039 (0.844 – 1.280) | 0.715 |
Age (>60) | 0.154 (0.01953 – 1.225) | 0.045 ** | 0.562 (0.0354 – 2.392) | 0.049 ** |
Gender | 1.048 (0.554 – 1.981) | 0.886 | 1.729 (0.704 – 4.245) | 0.231 |
Stage | 1.644 (0.8567 – 3.156) | 0.135’ | 1.274 (0.494 – 3.286) | 0.615 |